| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.07B | 20.90B | 19.99B | 19.60B | 17.43B | 16.46B |
| Gross Profit | 5.52B | 5.51B | 5.50B | 4.50B | 4.13B | 3.87B |
| EBITDA | 2.44B | 2.44B | 2.59B | 1.80B | 1.72B | 1.69B |
| Net Income | 888.00M | 1.02B | 1.16B | 504.00M | 462.00M | 155.00M |
Balance Sheet | ||||||
| Total Assets | 23.27B | 22.47B | 20.26B | 18.35B | 17.22B | 16.12B |
| Cash, Cash Equivalents and Short-Term Investments | 1.70B | 1.70B | 1.71B | 1.30B | 1.28B | 1.11B |
| Total Debt | 5.68B | 5.64B | 5.21B | 6.07B | 7.41B | 8.24B |
| Total Liabilities | 14.67B | 13.96B | 12.75B | 13.15B | 12.54B | 12.08B |
| Stockholders Equity | 8.49B | 8.40B | 7.42B | 5.13B | 4.63B | 3.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.85B | 587.00M | 152.00M | 392.00M | -296.00M |
| Operating Cash Flow | 0.00 | 181.00M | 2.65B | 1.77B | 1.59B | 1.26B |
| Investing Cash Flow | 0.00 | -490.00M | -1.94B | -371.00M | -614.00M | -1.81B |
| Financing Cash Flow | 0.00 | 243.00M | -327.00M | -1.40B | -858.00M | 893.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥7.57B | 0.81 | ― | 1.96% | 8.43% | 2.99% | |
72 Outperform | ¥9.08B | 23.47 | ― | 2.97% | 9.92% | -27.64% | |
69 Neutral | ¥9.18B | 20.79 | ― | 2.98% | -9.60% | -38.34% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥8.57B | 10.07 | ― | 1.93% | 13.64% | -151.98% | |
60 Neutral | ¥11.21B | 15.26 | ― | 1.06% | -9.63% | -1.71% | |
48 Neutral | ¥13.27B | 13.41 | -7.76% | ― | -19.70% | -159.15% |